FDA — authorised 19 November 1948
- Application: NDA006488
- Marketing authorisation holder: FRESENIUS KABI USA
- Status: supplemented
FDA authorised Xylocaine on 19 November 1948
Yes. FDA authorised it on 19 November 1948; FDA authorised it on 22 January 1985; FDA authorised it on 14 January 1986.
FRESENIUS KABI USA holds the US marketing authorisation.